Sensei Biotherapeutics/$SNSE
13:30
09:10
04:45
00:25
20:00
1D1W1MYTD1Y5YMAX
About Sensei Biotherapeutics
Sensei Biotherapeutics Inc is a clinical-stage biotechnology company engaged in the development of therapies targeting cancer through multi-node inhibition of oncogenic pathways. The company's lead program, PIKTOR, is an investigational oral combination therapy designed to inhibit multiple nodes of the PI3K/AKT/mTOR pathway and is being evaluated for the treatment of endometrial and breast cancers. In addition, the company is advancing other pipeline programs targeting tumor metabolism and signaling pathways.
Ticker
$SNSE
Sector
Primary listing
Employees
15
Headquarters
Website
SNSE Metrics
BasicAdvanced
$36m
-
-$16.72
-0.10
-
Price and volume
Market cap
$36m
Beta
-0.1
52-week high
$36.76
52-week low
$5.86
Average daily volume
51k
Financial strength
Current ratio
5.059
Quick ratio
4.983
Long term debt to equity
0.317
Total debt to equity
8.116
Interest coverage (TTM)
-696.50%
Profitability
EBITDA (TTM)
-22.149
Management effectiveness
Return on assets (TTM)
-40.81%
Return on equity (TTM)
-74.01%
Valuation
Price to book
1.83
Price to tangible book (TTM)
1.83
Price to free cash flow (TTM)
-1.661
Free cash flow yield (TTM)
-60.22%
Free cash flow per share (TTM)
-16.235
Growth
Earnings per share change (TTM)
-30.36%
3-year earnings per share growth (CAGR)
-19.15%
SNSE News
AllArticlesVideos
Sensei Biotherapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference
Business Wire·4 weeks ago
Sensei Biotherapeutics Reports Full Year 2025 Financial Results and Provides Corporate Update
Business Wire·1 month ago
Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Sensei Biotherapeutics stock?
Sensei Biotherapeutics (SNSE) has a market cap of $36M as of May 04, 2026.
What is the P/E ratio for Sensei Biotherapeutics stock?
The price to earnings (P/E) ratio for Sensei Biotherapeutics (SNSE) stock is 0 as of May 04, 2026.
Does Sensei Biotherapeutics stock pay dividends?
No, Sensei Biotherapeutics (SNSE) stock does not pay dividends to its shareholders as of May 04, 2026.
When is the next Sensei Biotherapeutics dividend payment date?
Sensei Biotherapeutics (SNSE) stock does not pay dividends to its shareholders.
What is the beta indicator for Sensei Biotherapeutics?
Sensei Biotherapeutics (SNSE) has a beta rating of -0.1. This means that it has an inverse relation to market volatility.